Paraoxonase-2 (PON2) in brain and its potential role in neuroprotection

NeuroToxicology

Volumn 43, Issue , 2014, Pages 3-9

  Costa, Lucio G ^a,c   De Laat, Rian ^a   Dao, Khoi ^a   Pellacani, Claudia ^c   Cole, Toby B ^a,b   Furlong, Clement E ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

Gender differences; Neuroprotection; Oxidative stress; Paraoxonase 2

Indexed keywords

ARACHIDONIC ACID; ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE 2; ATORVASTATIN; ESTRADIOL; GLABIDRIN; MESSENGER RNA; PARAOXONASE 3; PHYTOESTROGEN; QUERCETIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; UROKINASE; ARYLESTERASE; GLUCONOLACTONASE; NEUROLEPTIC AGENT; NEUROPROTECTIVE AGENT; PON2 PROTEIN, HUMAN;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN MITOCHONDRION; CELLULAR DISTRIBUTION; CORPUS STRIATUM; DISEASE PREDISPOSITION; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; POMEGRANATE JUICE; PON2 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; ASTROCYTE; BRAIN; BRAIN NERVE CELL; CYTOTOXICITY; MITOCHONDRIAL MEMBRANE; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM INFLAMMATION; NEUROMODULATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION; ANIMAL; FEMALE; GENETICS; MALE; METABOLISM; MITOCHONDRION; MOUSE;

MUS;

ANIMALS; ANTIPSYCHOTIC AGENTS; ARYLDIALKYLPHOSPHATASE; BRAIN; FEMALE; HUMANS; MALE; MICE; MITOCHONDRIA; NEUROPROTECTIVE AGENTS;

EID: 84905910325     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2013.08.011     Document Type: Article

References (89)

1. Altenhofer S., Witte I., Teiber J.F., Wilgenbus P., Pautz A., Li H., et al. One enzyme, two functions. PON2 prevents mitochondrial superoxide formation and apoptosis independent from its lactonase activity. J Biol Chem 2010, 285:24398-24403.
2. Arevalo M.A., Santos-Galindo M., Bellini M.J., Azcoitia I., Garcia-Segura L.M. Actions of estrogens on glial cells: implications for neuroprotection. Biochim Biophys Acta 2010, 1800:1106-1112.
3. Arnold S., Victor M.B., Beyer C. Estrogen and the regulation of mitochondrial structure and function in the brain. J Steroid Biochem Mol Biol 2012, 131:2-9.
4. Azcoita I., Arevalo M.A., De Nicola A.F., Garcia-Segura L.M. Neuroprotective actions of estradiol revisited. Trends Endocrinol Metab 2011, 22:467-473.
5. Barcelos G.R.M., Grotto D., Serpeloni J.M., Angeli J.P.F., Rocha B.A., Souza V.V.O., et al. Protective properties of quercetin against DNA damage and oxidative stress induced by methylmercury in rats. Arch Toxicol 2011, 85:1151-1157.
6. Beaulieu J.M., Gainetdinov R.R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Res 2011, 63:182-217.
7. Boesch-Saadatmandi C., Pospissil R.T., Graeser A.C., Canali R., Boomgaarden I., Doering F., et al. Effect of quercetin on paraoxonase 2 levels in RAW264.7 macrophages and in human monocytes - role of quercetin metabolism. Int J Mol Sci 2009, 10:4168-4177.
8. +-induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons. Cell Mol Neurobiol 2009, 29:1169-1180.
9. Bourquard N., Ng C.J., Reddy S.T. Impaired hepatic insulin signaling in PON2-deficient mice: a novel role for the PON2/apoE axis on the macrophage inflammatory response. Biochem J 2011, 436:91-100.
10. Bourque M., Liu B., Dluzen D.E., Di Paolo T. Sex differences in methamphetamine toxicity in mice: effect on brain dopamine signaling pathways. Psychoneuroendocrinology 2011, 36:955-969.
11. Camps J., Marsillach J., Joven J. Pharmacological and lifestyle factors modulating serum paraoxonase-1 activity. Mini Rev Med Chem 2009, 9:911-920.
12. Chen Q., Reis S.E., Kammerer C.M., McNamara D.M., Holubkov R., Sharaf B.L., et al. Association between severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Intitute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Am J Hum Genet 2003, 72:13-22.
13. Cole T.B., Jampsa R.L., Walter B.J., Arndt T.L., Richter R.J., Shih D.M., et al. Expression of human paraoxonase (PON1) during development. Pharmacogenetics 2003, 13:357-364.
14. Costa L.G., Cole T.B., Jarvik G.P., Furlong C.E. Functional genomics of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annu Rev Med 2003, 54:371-392.
15. Costa L.G., Vitalone A., Cole T.B., Furlong C.E. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 2005, 69:541-550.
16. Costa L.G., Giordano G., Furlong C.E. Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on. Biochem Pharmacol 2011, 81:337-344.
17. Costa L.G., Tait L., de Laat R., Dao K., Giordano G., Pellacani C., et al. Modulation of paraoxonase 2 (PON2) in mouse brain by the polyphenol quercetin; a mechanism of neuroprotection?. Neurochem Res 2013, 38:1809-1818.
18. Depino A.M. Peripheral and central inflammation in autism spectrum disorders. Mol Cell Neurosci 2013, 53:69-76.
19. Devarajan A., Bourquard N., Hama S., Navab M., Grijalva V.R., Morvardi S., et al. Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis. Antioxid Redox Signal 2011, 14:341-351.
20. Dluzen D.E., McDermott J.L., Darvesh A.S. Relationships among gender, age, time, and temperature in methamphetamine-induced striatal dopaminergic neurotoxicity. Neuroscience 2010, 167:985-993.
21. Draganov D.I., La Du B.N. Pharmacogenetics of paraoxonase: a brief review. Naunyn-Schmiedeberg's Arch Pharmacol 2004, 369:78-88.
22. Draganov D.I., Teiber J.F., Speelman A., Osawa Y., Sunahara R., La Du B.N. Human paraoxonases (PON1, PON2 and PON3) are lactonases with overlapping and distinct substrate specificities. J Lipid Res 2005, 46:1239-1247.
23. Fuhrman B., Khateeb J., Shiner M., Nitzan O., Karry R., Volkova N., et al. Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism. Arterioscler Thromb Vasc Res 2008, 28:1361-1367.
24. Fuhrman B., Gantman A., Khateeb J., Volkova N., Horke S., Kiyan J., et al. Urokinase activates macrophage PON2 gene transcription via the PI3K/ROS/MEK/SREBP-2 signalling cascade mediated by the PDGFR-beta. Cardiovasc Res 2009, 84:145-154.
25. Furlong C.E., Richter R.J., Li W.F., Brophy V.H., Carlson C., Rieder M., Nickerson D., Costa L.G., Ranchalis J., Lusis A.J., Shih D.M., Tward A., Jarvik G.P. The functional consequences of polymorphisms in the human PON1 gene. The paraoxonases: their role in disease development and xenobiotic metabolism 2008, 267-281. Springer. B. Mackness, M. Mackness, M. Aviram, G. Paragh (Eds.).
26. Galluzzo P., Martini C., Bulzomi P., Leone S., Bolli A., Pallottini V., et al. Quercetin-induced apoptotic cascade in cancer cells: antioxidant versus estrogen receptor alpha-dependent mechanisms. Mol Nutr Food Res 2009, 53:699-708.
27. Giordano G., Cole T.B., Furlong C.E., Costa L.G. Paraoxonase 2 (PON2) in the mouse central nervous system: a neuroprotective role. Toxicol Appl Pharmacol 2011, 256:369-378.
28. Giordano G., Tait L., Furlong C.E., Cole T.B., Kavanagh T.J., Costa L.G. Gender differences in brain susceptibility to oxidative stress are mediated by levels of paraoxonase-2 (PON2) expression. Free Radic Biol Med 2013, 58:98-108.
29. Giordano G., Engstrom A., Weldy C.S., Kavanagh T.J., Farin F., Costa L.G. Higher susceptibility of male mice to diesel exhaust neurotoxicity. Toxicologist 2013.
30. Granado-Serrano A.B., Martin M.A., Bravo L., Goya L., Ramos S. Quercetin modulates Nf-kB and AP-1/JNK pathways to induce cell death in human hepatoma cells. Nutr Cancer 2010, 62:390-401.
31. Guevara R., Gianotti M., Oliver J., Roca P. Age and sex-related changes in rat brain mitochondria oxidative stress. Exp Gerontol 2011, 46:923-928.
32. Halliwell B. Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies. Arch Biochem Biophys 2008, 476:107-112.
33. Hayashi M. Oxidative stress in developmental brain disorders. Neuropathology 2009, 29:1-8.
34. Higgins G.C., Beart P.M., Shin Y.S., Chen M.J., Cheung N.S., Nagley P. Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury. J Alzheimers Dis 2010, 20(Suppl. 2):S453-S473.
35. Horke S., Witte I., Wilgenbus P., Kruger M., Starnd D., Forstermann U. Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation. Circulation 2007, 115:2055-2064.
36. Horke S., Witte I., Altenhoffer S., Wilgenbus P., Goldeck M., Forstermann U., et al. Paraoxonase-2 is down regulated by the Pseudomonas aeruginosa quorum-sensing signal N-(3-oxododecanyl)-l-homoserine lactone and attenuates oxidative stress induced by pyocyanin. Biochem J 2010, 426:73-83.
37. Kardys I., Vliegenthart R., Oudkerk M., Hofman A., Witteman J.C.M. The female advantage in cardiovascular disease: do vascular beds contribute equally. Am J Epidemiol 2007, 166:403-412.
38. Klein S.L. The effects of hormones on sex differences in infection: from genes to behavior. Neurosci Biobehav Rev 2000, 24:627-638.
39. Levy E., Trudel K., Bendayan M., Seidman E., Delvin E., Elchebly M., et al. Biological role, protein expression, subcellular localization, and oxidative stress response of paraoxonase 2 in the intestine of human and rats. Am J Physiol Gastrointest Liver Physiol 2007, 293:G1252-G1261.
40. Li B.H., Zhang L.L., Yin Y.W., Pi Y., Yang Q.W., Gao C.Y., et al. Association between paraoxonase 2 Ser311Cys polymorphism and ischemic stroke risk: a meta-analysis involving 5,008 subjects. Mol Biol Rep 2012, 39:5623-5630.
41. Li W.F., Matthews C., Disteche C.M., Costa L.G., Furlong C.E. Paraoxonase (Pon1) gene in mice: sequencing, chromosomal localization and developmental expression. Pharmacogenetics 1997, 7:137-144.
42. Li W.F., Costa L.G., Richter R.J., Hagen T., Shih D.M., Tward A., et al. Catalytic efficiency determines the in vivo efficacy of PON1 for detoxifying organophosphates. Pharmacogenetics 2000, 10:767-779.
43. Lim J.A., Kim S.H. Transcriptional activation of an anti-oxidant mouse Pon2 gene by dexamethasone. BMB Rep 2009, 42:421-426.
44. Lv C., Hong T., yang Z., Zhang Y., Wang L., Dong M., Zhao J., Mu J., Meng Y. Effect of quercetin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease. Evid Based Complem Altern Med 2012, 6. ID 928643. 10.1155/2012/928643.
45. Mackness B., McElduff P., Mackness M.I. The paraoxonase-2 310 polymorphism is associated with the presence of microvascular complications in diabetes mellitus. J Intern Med 2005, 258:363-368.
46. Mackness B., Beltran-Debon R., Aragones G., Joven J., Camps J., Mackness M. Human tissue distribution of paraoxonases 1 and 2 mRNA. IUBMB Life 2010, 62:480-482.
47. Madison J.L., Wegrzynowicz M., Aschner M., Bowman A.B. Gender and manganese exposure interactions on mouse striatal neurons morphology. Neurotoxicology 2011, 32:896-906.
48. Marchegiani F., Spazzafumo L., Provinciali M., Cardelli M., Olivieri F., Franceschi C., et al. Paraoxonase 2 C311S polymorphism and low levels of HDL contribute to a higher mortality risk after acute myocardial infarction in elderly patients. Mol Genet Metab 2009, 98:314-318.
49. Marsillach J., Mackness B., Mackness M., Riu F., Beltran R., Joven J., et al. Immunohistochemical analysis of paraoxonase-1, 2 and 3 expression in normal mouse tissues. Free Radic Biol Med 2008, 45:146-157.
50. Meilin E., Aviram M., Hayek T. Paraoxonase 2 (PON2) decreases high glucose-induced macrophage triglyceride (TG) accumulation, via inhibition of NADPH-oxidase and DGAT1 activity: studies in PON2-deficient mice. Atherosclerosis 2010, 208:390-395.
51. Mercer L.D., Kelly B.L., Horne M.K., Beart P.M. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis; investigations in primary rat mesencephalic cultures. Biochem Pharmacol 2005, 69:339-345.
52. Misiak M., Beyer C., Arnold S. Gender-specific role of mitochondria in the vulnerability of 6-hydroxydopamine-treated mesencephalic neurons. Biochim Biophys Acta 2010, 1797:1178-1188.
53. Mochizuki H., Scherer S.W., Xi T., Nickle D.C., Majer M., Huizenga J.J., et al. Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence. Gene 1998, 213:149-157.
54. Ng C.J., Wadleigh D.J., Gangopadhyyay A., Hama S., Grijalva V.R., Navab M., et al. Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J Biol Chem 2001, 276:44444-44449.
55. Ng C.J., Bourquard N., Grijalva V., Hama S., Shih D.M., Navab M., et al. Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins antiatherogenic role for paraoxonase-2. J Biol Chem 2006, 281:29491-29500.
56. Ng C.J., Hama S.Y., Bourquard N., Navab M., Reddy S.T. Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein E-deficient mice. Mol Genet Metab 2006, 89:368-373.
57. Niranjan R. The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes. Mol Neurobiol 2013, (in press).
58. Ossola B., Kaariainen T.M., Mannisto P.T. The multiple faces of quercetin in neuroprotection. Expert Opin Drug Saf 2009, 8:397-409.
59. Precourt L.P., Seidman E., Delvin E., Amre D., Deslandres C., Dominguez M., et al. Comparative expression analysis reveals differences in the regulation of intestinal paraoxonase family members. Int J Biochem Mol Biol 2009, 41:1628-1637.
60. Precourt L.P., Amre D., Denis M.C., Lavoie J.C., Delvin E., Seidman E., et al. The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis 2011, 214:20-36.
61. Primo-Parmo S.L., Sorenson R.C., Teiber J., La Du B.N. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 1996, 33:498-507.
62. Rosenblat M., Draganov D., Watson C.E., Bisgaier C.L., La Du B.N., Aviram M. Mouse macrophage paraoxonase-2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress. Arterioscler Thromb Vasc Biol 2003, 23:468-474.
63. Rosenblat M., Hayek T., Hussein K., Aviram M. Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy. Arterioscler Thromb Vasc Biol 2004, 24:175-180.
64. Rosenblat M., Coleman R., Reddy S.T., Aviram M. Paraoxonase 2 attenuates macrophage triglyceride accumulation via inhibition of diacylglycerol acyltransferase 1. J Lipid Res 2009, 50:870-879.
65. Rosenblat M., Volkova N., Roqueta-Rovera M., Nakamura M.T., Aviram M. Increased macrophage cholesterol biosysnthesis and decreased cellular paraoxonase 2 (PON2) expression in Δ 6-desaturase knockout (6-DS-KO) mice: beneficial effects of arachidonic acid. Atherosclerosis 2010, 210:414-421.
66. Schweikert E.M., Amort J., Wilgenbus P., Forsterman U., Teiber J.F., Horke S. Paraoxonases-2 and -3 are important defense enzymes against Pseudomonas aeruginosa virulence factors due to their anti-oxidative and anti-inflammatory properties. J Lipids 2012, ID 352857.
67. Selvakumar K., Bavithra S., Suganthi M., Benson C.S., Elumalai P., Arunkumar R., et al. Protective role of quercetin on PCBs-induced oxidative stress and apoptosis in hippocampus of adult rats. Neurochem Res 2012, 37:708-721.
68. Shamir R., Hartman C., Karry R., Pavlotzky E., Eliakim R., Lachter J., et al. (PONs) 1, 2 and 3 are expressed in human and mouse gastrointestinal tract and in Caco-2 cell line: selective secretion of PON1 and PON2. Free Radic Biol Med 2005, 39:336-344.
69. Shi J., Zhang S., Tang M., Liu X., Li T., Han H., et al. Possible association between Cys311Ser polymorphism of paraoxonase 2 gene and late-onset Alzheimer's disease in Chinese. Mol Brain Res 2004, 120:201-204.
70. Shiner M., Fuhrman B., Aviram M. Paraoxonase 2 (PON2) expression is upregulated via a reduced nicotinamide-adenine-dinucleotide-phosphate (NADPH)-dependent mechanism during monocytes differentiation into macrophages. Free Radic Biol Med 2004, 37:2052-2063.
71. Shiner M., Fuhrman B., Aviram M. Macrophage paraoxonase 2 (PON2) expression is upregulated by unesterified cholesterol through activation of the phosphatidylinositol 3-kinase (PI3K) pathway. Biol Chem 2007, 388:1353-1358.
72. Shiner M., Fuhrman B., Aviram M. Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPARγ and AP-1 pathway activation. Atherosclerosis 2007, 195:313-321.
73. Simpkins J.W., Yi K.D., Yang S.H., Dykens J.A. Mitochondrial mechanisms of estrogen neuroprotection. Biochim Biophys Acta 2010, 1800:1113-1120.
74. Stoltz D.A., Ozer E.A., Ng C.J., Yu J.M., Reddy S.T., Lusis A.J., et al. Paraoxonase-2 deficiency enhances Pseudomonas aeruginosa quorum sensing in murine tracheal epithelia. Am J Physiol Lung Cell Mol Physiol 2007, 292:L852-L860.
75. Stoltz D.A., Ozer E.A., Recker T.J., Estin M., Yang X., Shih D.M., et al. A common mutation in paraoxonase-2 results in impaired lactonase activity. J Biol Chem 2009, 284:35564-35571.
76. Stucker Fernandez E., de Oliveira Machado M., Minuzzi Becker A., de Andrade F., Maraschin M., Luiz da Silva E. Yerba mate (Ilex paraguariensis) enhances the gene modulation and activity of paraoxonase-2: in vitro and in vivo studies. Nutrition 2012, 28:1157-1164.
77. Sundar-Boyalla S., Victor M.B., Roemgren A., Beyer C., Arnold S. Sex-and brain region specific role of cytochrome c oxidase in 1-methyl-4-phenylpyridinium-mediated astrocyte vulnerability. J Neurosci Res 2011, 89:2068-2082.
78. Surmeier D.J., Guzman J.N., Sanchez-Padilla J., Goldberg J.A. The origins of oxidant stress in Parkinson's disease and therapeutic strategies. Antioxid Redox Signal 2011, 14:1289-1301.
79. Tamas A., Lubics A., Szalontay L., Lengvari I., Reglodi D. Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine-induced lesion of the substantia nigra. Behav Brain Res 2005, 158:221-229.
80. Teiber J.F., Horke S., Haines D.C., Chowdhary P.K., Xiao J., Kramer G.L., et al. Dominant role of paraoxonases in inactivation of the Pseudomonas aeruginosa quorum-sensing signal N-(3-oxododecanoyl)-l-homoserine lactone. Infect Immun 2008, 76:2512-2519.
81. Vahter M., Gochfield M., Casati B., Thiruchelvam M., Falk-Filippson A., Kavlock R., et al. Implications of gender differences for human health risk assessment and toxicology. Environ Res 2007, 104:70-84.
82. Van den Eeden S.K., Tanner C.M., Bernstein A.L., Fross R.D., Leimpeter A., Bloch D.A., et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003, 157:1015-1022.
83. Wald C., Wu C. Of mice and women: the bias in animal research. Science 2010, 327:1571-1572.
84. Wang F., He Q., Sun Y., Dai X., Yang X.P. Female adult mouse cardiomyocytes are protected against oxidative stress. Hypertension 2010, 55:1172-1178.
85. Weiss B. Same sex, no sex, and unaware sex in neurotoxicology. Neurotoxicology 2011, 32:509-517.
86. Wirdefeld K., Adami H.O., Cole P., Trichopoulos D., Mandel J. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol 2011, 26:S1-S58.
87. Witte I., Altenhöfer S., Wilgenbus P., Amort J., Clement A.M., Pautz A., Li H., Förstermann U., Horke S. Beyond reduction of atherosclerosis: PON2 provides apoptosis resistance and stabilizes tumor cells. Cell Death Dis 2011, 2:e112. 10.1038/cddis.2010.91.
88. Yang Y., Zhang Y., Cuevas-Gonzalez S., Villar V.A., Escano C., Asico L., et al. Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase. Free Radic Biol Med 2012, 53:437-446.
89. Yehuda I., Madar Z., Szuchman-Sapir A., Tamir S. Glabridin a phytoestrogen from licorice root, up-regulates manganese superoxide dismutase, catalase and paraoxonase 2 under glucose stress. Phytother Res 2011, 25:659-667.